vs

Side-by-side financial comparison of HEALTHSTREAM INC (HSTM) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $79.7M, roughly 1.0× HEALTHSTREAM INC). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 7.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 4.7%).

HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

HSTM vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.0× larger
PRCT
$83.1M
$79.7M
HSTM
Growing faster (revenue YoY)
PRCT
PRCT
+12.8% gap
PRCT
20.2%
7.4%
HSTM
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
4.7%
HSTM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HSTM
HSTM
PRCT
PRCT
Revenue
$79.7M
$83.1M
Net Profit
$-31.6M
Gross Margin
64.9%
Operating Margin
3.0%
-4.1%
Net Margin
-38.1%
Revenue YoY
7.4%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.09
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HSTM
HSTM
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$79.7M
$76.4M
Q3 25
$76.5M
$83.3M
Q2 25
$74.4M
$79.2M
Q1 25
$73.5M
$69.2M
Q4 24
$74.2M
$68.2M
Q3 24
$73.1M
$58.4M
Q2 24
$71.6M
$53.4M
Net Profit
HSTM
HSTM
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$6.1M
$-21.4M
Q2 25
$5.4M
$-19.6M
Q1 25
$4.3M
$-24.7M
Q4 24
$-18.9M
Q3 24
$5.7M
$-21.0M
Q2 24
$4.2M
$-25.6M
Gross Margin
HSTM
HSTM
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
HSTM
HSTM
PRCT
PRCT
Q1 26
-4.1%
Q4 25
3.0%
-40.6%
Q3 25
9.9%
-27.8%
Q2 25
7.9%
-28.0%
Q1 25
6.0%
-39.7%
Q4 24
6.3%
-28.9%
Q3 24
8.9%
-38.4%
Q2 24
6.2%
-50.3%
Net Margin
HSTM
HSTM
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
8.0%
-25.7%
Q2 25
7.2%
-24.7%
Q1 25
5.9%
-35.8%
Q4 24
-27.6%
Q3 24
7.8%
-35.9%
Q2 24
5.8%
-48.0%
EPS (diluted)
HSTM
HSTM
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.09
$-0.54
Q3 25
$0.20
$-0.38
Q2 25
$0.18
$-0.35
Q1 25
$0.14
$-0.45
Q4 24
$0.16
$-0.34
Q3 24
$0.19
$-0.40
Q2 24
$0.14
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HSTM
HSTM
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$36.2M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$354.0M
$347.7M
Total Assets
$520.4M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HSTM
HSTM
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$36.2M
$286.5M
Q3 25
$53.5M
$294.3M
Q2 25
$52.1M
$302.7M
Q1 25
$77.3M
$316.2M
Q4 24
$59.5M
$333.7M
Q3 24
$57.5M
$196.8M
Q2 24
$46.1M
$214.1M
Total Debt
HSTM
HSTM
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
HSTM
HSTM
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$354.0M
$365.9M
Q3 25
$349.2M
$380.3M
Q2 25
$350.6M
$385.8M
Q1 25
$362.8M
$389.2M
Q4 24
$359.4M
$402.2M
Q3 24
$355.5M
$241.2M
Q2 24
$349.2M
$251.8M
Total Assets
HSTM
HSTM
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$520.4M
$508.1M
Q3 25
$499.9M
$511.5M
Q2 25
$500.1M
$513.1M
Q1 25
$524.0M
$519.4M
Q4 24
$510.8M
$534.0M
Q3 24
$502.8M
$374.1M
Q2 24
$499.6M
$374.4M
Debt / Equity
HSTM
HSTM
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HSTM
HSTM
PRCT
PRCT
Operating Cash FlowLast quarter
$13.2M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
16.3%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$59.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HSTM
HSTM
PRCT
PRCT
Q1 26
Q4 25
$13.2M
$-10.3M
Q3 25
$18.0M
$-6.6M
Q2 25
$5.0M
$-15.0M
Q1 25
$27.1M
$-17.0M
Q4 24
$11.2M
$-32.4M
Q3 24
$19.1M
$-18.8M
Q2 24
$6.5M
$-15.7M
Free Cash Flow
HSTM
HSTM
PRCT
PRCT
Q1 26
Q4 25
$13.0M
$-12.2M
Q3 25
$17.9M
$-9.5M
Q2 25
$2.7M
$-17.8M
Q1 25
$26.0M
$-18.8M
Q4 24
$11.0M
$-33.6M
Q3 24
$18.8M
$-19.0M
Q2 24
$6.3M
$-16.8M
FCF Margin
HSTM
HSTM
PRCT
PRCT
Q1 26
Q4 25
16.3%
-15.9%
Q3 25
23.4%
-11.4%
Q2 25
3.6%
-22.5%
Q1 25
35.4%
-27.2%
Q4 24
14.8%
-49.2%
Q3 24
25.8%
-32.6%
Q2 24
8.8%
-31.4%
Capex Intensity
HSTM
HSTM
PRCT
PRCT
Q1 26
Q4 25
0.3%
2.4%
Q3 25
0.1%
3.4%
Q2 25
3.1%
3.5%
Q1 25
1.4%
2.7%
Q4 24
0.3%
1.7%
Q3 24
0.4%
0.4%
Q2 24
0.2%
2.0%
Cash Conversion
HSTM
HSTM
PRCT
PRCT
Q1 26
Q4 25
Q3 25
2.96×
Q2 25
0.93×
Q1 25
6.25×
Q4 24
Q3 24
3.34×
Q2 24
1.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HSTM
HSTM

Subscription Services$77.0M97%
Professional Services$2.7M3%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons